SSTR-positive neuroendocrine tumors: peptide receptor radionuclide therapy

被引：0
|
作者：
不详
机构：
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S69
页数：4
相关论文
共 50 条
  • [41] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [42] SSTR-directed Peptide Receptor Radionuclide Therapy in recurrent Meningioma
    Hartrampf, P.
    Mueller, M.
    Serfling, S. E.
    Buck, A. K.
    Polat, B.
    Werner, R. A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S672 - S672
  • [43] Initial experience with somatostatin receptor (SSTR) imaging and peptide receptor radionuclide therapy for patients with neuroendocrine differentiation (NED) of prostate cancer
    Assadi, M.
    Rekabpour, S.
    Ahmadzadehfar, H.
    Jafari, E.
    Amini, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S697
  • [44] Peptide receptor radionuclide therapy in patients with pulmonary neuroendocrine tumors: our experience.
    Minutoli, F.
    Cardile, D.
    Cucinotta, M.
    Quartuccio, N.
    Gangemi, V.
    Sindoni, A.
    Baldari, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S531 - S531
  • [45] Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Shimamura, Takeshi
    Takano, Shoko
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Ichikawa, Yasushi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (09) : 727 - 739
  • [46] The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors: a meta-analysis
    Dannoon, Shorouk F.
    Alenezi, Saud A.
    Elgazzar, Abdelhamid H.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1085 - 1093
  • [47] Lu-177-Based Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Kim K.
    Kim S.-J.
    Nuclear Medicine and Molecular Imaging, 2018, 52 (3) : 208 - 215
  • [48] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [49] Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths
    Vikas Prasad
    Lisa Bodei
    Mark Kidd
    Irvin M. Modlin
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1825 - 1830
  • [50] Peptide receptor radionuclide therapy for advanced gastroenteropancreatic neuroendocrine tumors - from oncology perspective
    Kolasinska-Cwikla, Agnieszka
    Lowczak, Anna
    Maciejkiewicz, Katarzyna
    Cwikla, Jaroslaw B.
    NUCLEAR MEDICINE REVIEW, 2018, 21 (02) : 115 - 124
12345